Literature DB >> 25061652

[Significant cardiotoxicity of trastuzumab in adjuvant systemic therapy of elderly patients with breast cancer].

Fabian Pohl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25061652     DOI： 10.1007/s00066-014-0683-4

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  7 in total

1.  Trastuzumab-related cardiotoxicity among older patients with breast cancer.

Authors:  Mariana Chavez-MacGregor; Ning Zhang; Thomas A Buchholz; Yufeng Zhang; Jiangong Niu; Linda Elting; Benjamin D Smith; Gabriel N Hortobagyi; Sharon H Giordano
Journal:  J Clin Oncol       Date:  2013-10-14       Impact factor: 44.544

2.  Late Toxicity of Radiotherapy: A Problem or a Challenge for the Radiation Oncologist?

Authors:  Cordula Petersen; Florian Würschmidt
Journal:  Breast Care (Basel)       Date:  2011-10-31       Impact factor: 2.860

3.  Subclinical cardiotoxicity detected by strain rate imaging up to 14 months after breast radiation therapy.

Authors:  Katrien Erven; Anca Florian; Pieter Slagmolen; Caroline Sweldens; Ruxandra Jurcut; Hans Wildiers; Jens-Uwe Voigt; Caroline Weltens
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-11-10       Impact factor: 7.038

4.  Risk of ischemic heart disease in women after radiotherapy for breast cancer.

Authors:  Sarah C Darby; Marianne Ewertz; Paul McGale; Anna M Bennet; Ulla Blom-Goldman; Dorthe Brønnum; Candace Correa; David Cutter; Giovanna Gagliardi; Bruna Gigante; Maj-Britt Jensen; Andrew Nisbet; Richard Peto; Kazem Rahimi; Carolyn Taylor; Per Hall
Journal:  N Engl J Med       Date:  2013-03-14       Impact factor: 91.245

Review 5.  [Is cardiotoxicity still an issue after breast-conserving surgery and could it be reduced by multifield IMRT?].

Authors:  Frank Lohr; Felix Heggemann; Theano Papavassiliu; Mostafa El-Haddad; Oliver Tomé; Dietmar Dinter; Barbara Dobler; Uta Kraus-Tiefenbacher; Martin Borggrefe; Frederik Wenz
Journal:  Strahlenther Onkol       Date:  2009-04-16       Impact factor: 3.621

6.  Radiotherapy and adjuvant trastuzumab in operable breast cancer: tolerability and adverse event data from the NCCTG Phase III Trial N9831.

Authors:  Michele Y Halyard; Thomas M Pisansky; Amylou C Dueck; Vera Suman; Lori Pierce; Larry Solin; Larry Marks; Nancy Davidson; Silvana Martino; Peter Kaufman; Leila Kutteh; Shaker R Dakhil; Edith A Perez
Journal:  J Clin Oncol       Date:  2009-04-06       Impact factor: 44.544

7.  Cardiotoxicity and cancer therapy: treatment-related cardiac morbidity in patients presenting with symptoms suggestive of heart or lung disease.

Authors:  Siegfried Wieshammer; Jens Dreyhaupt; Dirk Müller; Felix Momm; Andreas Jakob; Ulrich Freund
Journal:  Oncology       Date:  2013-08-15       Impact factor: 2.935
  7 in total
  2 in total

1.  DEGRO practical guidelines for radiotherapy of breast cancer V: Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with synchronous distant metastases.

Authors:  Wilfried Budach; Christiane Matuschek; Edwin Bölke; Jürgen Dunst; Petra Feyer; Rainer Fietkau; Wulf Haase; Wolfgang Harms; Marc D Piroth; Marie-Luise Sautter-Bihl; Felix Sedlmayer; Rainer Souchon; Frederik Wenz; Frederick Wenz; Rolf Sauer
Journal:  Strahlenther Onkol       Date:  2015-05-12       Impact factor: 3.621

2.  A Retrospective Comparison of Trastuzumab Plus Cisplatin and Trastuzumab Plus Capecitabine in Elderly HER2-Positive Advanced Gastric Cancer Patients.

Authors:  Bo Zhu; Jun-Rong Wu; Xiao-Ping Zhou
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.